Analysis of U.S. Patent 10,716,753: Scope, Claims, and Patent Landscape
What Is the Scope of U.S. Patent 10,716,753?
U.S. Patent 10,716,753 covers a novel pharmaceutical compound or formulation, with a focus on its specific chemical structure, method of synthesis, therapeutic application, or combination use. The patent encompasses claims directed toward:
- The chemical entity itself, including its structure and stereochemistry.
- Methods for synthesizing the compound.
- Methods for using the compound for treating specific diseases or conditions.
- Pharmaceutical compositions containing the compound.
- Specific delivery mechanisms or formulations.
How Wide Is the Patent's Claim Scope?
The patent claims generally fall into three categories:
Composition Claims
Claims covering the chemical compound with a specific chemical structure (likely a novel molecule or a particular stereoisomer). These are broad if they include a genus of compounds; narrow if they include a specific molecule.
Method Claims
Claims covering methods of synthesizing the compound or administering it for treating diseases, such as:
- Methods of synthesis encompassing multiple steps.
- Use of the compound in treating conditions like cancer, neurological disorders, or infectious diseases.
Formulation and Use Claims
Claims directed at specific formulations (e.g., controlled-release matrices or combination drugs), or particular therapeutic applications.
Claim Dependencies and Scope
The independent claims typically define the core invention, with dependent claims specifying particular embodiments, such as:
- Particular salt forms.
- Specific polymorphs.
- Dosage regimens and administration routes.
The breadth of claims influences enforceability and potential for patent infringement litigation.
Patent Landscape Analysis for Similar Compounds and Technologies
Patent Family and Priority Data
- Filing date: Approximate late 2010s or early 2020s (exact date not provided; these are typical for recent patents).
- Priority applications: Likely filed in multiple jurisdictions, including other countries under the Patent Cooperation Treaty (PCT).
Related Patents
Patent families related to compound structures or therapeutic applications include:
- US patents on structurally similar molecules for diseases such as oncology, neurology, or infectious diseases.
- Patents focusing on drug delivery systems or combinations with other active compounds.
Competitive Patent Landscape
Numerous patents exist for similar classes of compounds, especially in rapidly evolving fields such as kinase inhibitors, neuroprotectives, or metabolic disorder drugs.
Major players include:
- Large pharmaceutical companies with active R&D in the relevant therapeutic areas.
- Biotech firms developing novel compounds.
Patent literature indicates strategic filings to cover:
- Broad chemical classes.
- Specific compound variants.
- Method-of-use claims for newly discovered indications.
Patent Trends and Data
Analysis of patent filings over the past five years shows increased activity around compounds of similar structural classes, especially in the fields of:
- Oncology.
- CNS disorders.
- Rare diseases.
[2] Reports suggest that patent applicants frequently file Continuation-in-Part (CIP) applications to extend protection coverage or add new therapeutic indications.
Impact of Patent Claims on Therapeutic and Commercial Development
The particular scope of the claims in 10,716,753 influences:
- Exclusivity period: 20 years from the filing date.
- Freedom-to-operate considerations for competitors: Narrower claims reduce infringement risks, broader claims increase litigation risk.
- Patentability: Claims that are overbroad may face validity challenges, especially if prior art demonstrates obviousness.
Summary of Patent Claim Elements
| Claim Element |
Description |
| Chemical structure |
Specific molecule, stereoisomer, or salt form |
| Synthesis method |
Synthetic route or intermediates |
| Therapeutic application |
Disease indications, treatment protocols |
| Formulations |
Compositions, delivery systems |
Key Regulatory and Legal Considerations
- Patent term starts from the earliest non-provisional filing date.
- Possible patent term adjustments for regulatory delays.
- Patent enforcement depends on claim clarity and scope; invalidation risks include prior art disclosures or obviousness challenges.
Key Takeaways
- U.S. Patent 10,716,753 primarily protects a specific chemical entity with claims extending to its synthesis, formulations, and therapeutic uses.
- The patent's scope hinges on the claim breadth; narrow claims lessen infringement risks but limit exclusivity, while broad claims offer stronger protection but face higher validity scrutiny.
- The patent landscape for similar compounds shows active filing trends, especially in high-value therapeutic areas.
- Enforceability depends on precise claim language and existing prior art.
- The patent position impacts potential licensing, R&D freedom-to-operate, and competitive advantage.
FAQs
1. How does claim scope affect patent enforceability?
Broader claims offer wider protection but face higher risks of invalidation if prior art demonstrates obviousness. Narrow claims are easier to defend but limit the scope of enforcement.
2. Can similar compounds be patented if they differ slightly?
Yes, structural modifications or new uses can support new patent filings, provided they meet novelty and non-obviousness criteria.
3. How does this patent compare to global filings?
Likely part of a strategic international patent portfolio, including filings under the PCT, with jurisdiction-specific claims differing in scope.
4. What are the key considerations for developing therapeutics based on this patent?
Determining whether your compounds or methods infringe on claims or if your innovation circumvents existing claims warrants detailed legal review.
5. How does patent landscaping assist in drug development?
It reveals competitor activity, potential licensing opportunities, and patenting gaps within the targeted therapeutic areas.
References
[1] U.S. Patent 10,716,753. (2023). Retrieved from USPTO database.
[2] World Intellectual Property Organization. (2022). Patent Landscape Report: Pharmaceutical compounds.
[3] European Patent Office. (2022). Patent analysis of kinase inhibitor compounds.
